EconStor >
Stockholm School of Economics >
EFI - The Economic Research Institute, Stockholm School of Economics >
SSE/EFI Working Paper Series in Economics and Finance, EFI - The Economic Research Institute, Stockholm School of Economics >

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10419/56355
  

Full metadata record

DC FieldValueLanguage
dc.contributor.authorJönsson, Bengten_US
dc.contributor.authorLundkvist, Jonasen_US
dc.contributor.authorPersson, Björnen_US
dc.date.accessioned2012-03-28T13:11:05Z-
dc.date.available2012-03-28T13:11:05Z-
dc.date.issued2002en_US
dc.identifier.urihttp://hdl.handle.net/10419/56355-
dc.language.isosween_US
dc.publisherEkonomiska Forskningsinst. Stockholmen_US
dc.relation.ispartofseriesSSE/EFI Working Paper Series in Economics and Finance 505en_US
dc.subject.jelI11en_US
dc.subject.ddc330en_US
dc.subject.stwPharmazeutisches Produkten_US
dc.subject.stwSchwedenen_US
dc.subject.stwPharmazeutische Forschungen_US
dc.titleNya läkemedel i Sverige: Innovationshöjd, prissättning och marknadsframgången_US
dc.typeWorking Paperen_US
dc.identifier.ppn353676365en_US
dc.rightshttp://www.econstor.eu/dspace/Nutzungsbedingungenen_US
Appears in Collections:SSE/EFI Working Paper Series in Economics and Finance, EFI - The Economic Research Institute, Stockholm School of Economics

Files in This Item:
File Description SizeFormat
353676365.pdf985.53 kBAdobe PDF
No. of Downloads: Counter Stats
Show simple item record
Download bibliographical data as: BibTeX

Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.